New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Sabra Healthcare REIT, Inc.

SBRA

Real Estate Reit Healthcare Facilities

Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.

Revenue
+31.3%
EPS
+22.2%
Free cash flow
n/m
Total debt
−5.99%

Quarter to September 2026, against a year earlier

20.39 0.07 −0.34%

After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.

Market cap
$5.4B
P/E
72.8×
Fwd P/E FY26e
62.6×
Dividend yield
5.89%
F-score
5/9
ROIC
1.95%
Net debt / EBITDA
5.5×
Payout ratio
4.3×

Sabra Healthcare REIT, Inc. (SBRA) news

The news and the share price important stories, numbered as below

Share price since Oct 21 +7.9%

Stories the last two months, newest first

  1. 1 Results ·

    Sabra raises 2026 guidance after third-quarter FFO reaches $0.41 per share

    Sabra reported Q3 2026 normalized FFO of $0.39 per share and AFFO of $0.41, each up 8% year over year. SHOP same-store cash NOI grew 14.6%, supported by 9.3% revenue growth and higher occupancy. The company raised its 2026 guidance midpoint, projecting 7%–8% earnings growth, and reported $747.2 million of investments closed year to date, plus $425 million awarded.

    Reported by 8: Moby · Business Wire · The Motley Fool · MarketBeat · GuruFocus.com · The Motley Fool · Zacks · Associated Press

More headlines